EBioMedicine · 2022 · 25 citations · 37 references
Life SciencesInfectious DiseasesNeuroscienceImmunopathologyNeuroimmunologyNeuroinfectious DiseasesAutoimmune Neurological DisordersCentral Nervous System ImmunityEncephalitisNeuropathology Of InfectionPostinfectious Neurologic SyndromesAutoimmune Neurological DiseaseBrainstem InvolvementNeurological Viral InfectionsNeuronal AutoantibodiesViral Neuroimmunity
BACKGROUND: Understanding how SARS-CoV-2 affects respiratory centres in the brainstem may help to preclude assisted ventilation for patients in intensive care setting. Viral invasion appears unlikely, although autoimmunity has been implicated, the responsible antigens remain unknown. We previously predicted the involvement of three epitopes within distinct brainstem proteins: disabled homolog 1 (DAB1), apoptosis-inducing-factor-1 (AIFM1), and surfeit-locus-protein-1 (SURF1). METHODS: Here, we used microarrays to screen serum from COVID-19 patients admitted to intensive care and compared those with controls who experienced mild course of the disease. FINDINGS: The results confirm the occurrence of IgG and IgM antibodies against the hypothesised epitopes in COVID-19 patients. Importantly, while IgM levels were similar in both groups, IgG levels were significantly elevated in severely ill patients compared to controls, suggesting a pathogenic role of IgG. INTERPRETATION: The newly discovered anti-neuronal antibodies might be promising markers of severe disease and the targeted peptide epitopes might be used for targeted immunomodulation. Further work is needed to determine whether these antibodies may play a role in long-COVID. FUNDING: AF, CF and PR received support from the German Research Foundation (grants FL 379/22-1, 327654276-SFB 1315, FR 4479/1-1, PR 1274/8-1). SH, DR, and DB received support from the Ministry of Economy, State of Mecklenburg Western Pomerania, Germany (grant COVIDPROTECT: "Optimisation of diagnostic and therapeutic pathways for COVID-19 patients in MV"). SH received support from the Research Group Molecular Medicine University of Greifswald (FVMM, seed funding FOVB-2021-01). AV received support from the Else Kröner Fresenius Foundation and the Alzheimer Research Initiative.
37
Highly accurate protein structure prediction with AlphaFold
John Jumper, Alexander Pritzel, Tim Green et al. · Nature · 2021 · 45.2K citations · Full text
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text
The SWISS-MODEL Repository—new features and functionality
Stefan Bienert, Andrew Waterhouse, Tjaart de Beer et al. · Nucleic Acids Research · 2016 · 1.8K citations · Full text
COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features
Neo Poyiadji, Gassan Shahin, Daniel L. Noujaim et al. · Radiology · 2020 · 1.5K citations · Full text